Stereotactic versus whole-brain radiotherapy combined with immunotherapy in driver gene–negative NSCLC with brain metastases: a real-world IPTW analysis - Top-Institutions - MDSpire

Stereotactic versus whole-brain radiotherapy combined with immunotherapy in driver gene–negative NSCLC with brain metastases: a real-world IPTW analysis

  • By

  • Erha Munai

  • Lisi Sun

  • Amu Jike

  • Dan Tao

  • Nan Li

  • Jiang He

  • Yu He

  • Liang Du

  • Wei Zhou

  • Yongzhong Wu

  • Dingyi Yang

  • June 22, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Mass General Brigham Cancer Institute
    Mass General Brigham Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology

  • #2

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, MA

    Key Differentiators

    • Oncology

  • #3

    Radiation Oncology Center of Chongqing University Cancer Hospital
    Radiation Oncology Center of Chongqing University Cancer Hospital

    Chongqing, China

    Key Differentiators

    • Oncology

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Oncology

Original Source(s)

Stereotactic versus whole-brain radiotherapy combined with immunotherapy in driver gene–negative NSCLC with brain metastases: a real-world IPTW analysis

  • by Erha Munai, Lisi Sun, Amu Jike, Dan Tao, Nan Li, Jiang He, Yu He, Liang Du, Wei Zhou, Yongzhong Wu, Dingyi Yang

  • June 22, 2026

Related Content

Endocrine therapy and thyroid function in early luminal breast cancer: a controlled longitudinal retrospective analysis

Metachronous cholangiocarcinoma following pancreaticoduodenectomy and the potential role of a migrated pancreaticojejunal stent: a case report and review of the literature

Oncolytic virotherapy counteracts the selection of IFN-unresponsive cancer cells post-immunotherapy but is limited by the emergence of dedifferentiated cancer cells